Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Cancer | journal | 19.575 Q1 | 505 | 88 | 370 | 8894 | 9218 | 202 | 18.59 | 101.07 | 30.41 | |
2 | Cancer Treatment Reviews | journal | 4.278 Q1 | 164 | 106 | 345 | 9562 | 3879 | 341 | 11.50 | 90.21 | 43.55 | |
3 | Journal of Hematology and Oncology | journal | 4.305 Q1 | 144 | 163 | 440 | 14177 | 5901 | 436 | 14.91 | 86.98 | 42.41 | |
4 | Molecular Cancer | journal | 7.274 Q1 | 196 | 155 | 492 | 13169 | 11747 | 459 | 25.22 | 84.96 | 38.97 | |
5 | NAR Cancer | journal | 17 | 36 | 1 | 2962 | 0 | 0 | 0.00 | 82.28 | 41.08 | ||
6 | Expert Review of Anticancer Therapy | journal | 1.209 Q2 | 85 | 118 | 348 | 8783 | 1361 | 312 | 3.81 | 74.43 | 37.80 | |
7 | European Journal of Cancer, Supplement | journal | 29 | 11 | 0 | 804 | 0 | 0 | 0.00 | 73.09 | 60.71 | ||
8 | Best Practice and Research in Clinical Haematology | journal | 1.130 Q2 | 81 | 48 | 149 | 3011 | 463 | 141 | 2.92 | 62.73 | 38.95 | |
9 | npj Precision Oncology | journal | 36 | 33 | 61 | 2009 | 450 | 60 | 7.32 | 60.88 | 42.08 | ||
10 | Endocrine-Related Cancer | journal | 1.892 Q1 | 146 | 102 | 383 | 6194 | 2004 | 351 | 4.93 | 60.73 | 46.97 | |
11 | Experimental Hematology and Oncology | journal | 1.223 Q2 | 42 | 37 | 96 | 2219 | 372 | 95 | 4.33 | 59.97 | 48.34 | |
12 | Journal of Experimental and Clinical Cancer Research | journal | 2.752 Q1 | 120 | 252 | 904 | 14857 | 8592 | 904 | 9.79 | 58.96 | 45.97 | |
13 | European Oncology and Haematology | journal | 0.116 Q4 | 8 | 7 | 65 | 384 | 11 | 41 | 0.18 | 54.86 | 44.44 | |
14 | npj Breast Cancer | journal | 2.746 Q1 | 46 | 64 | 133 | 3428 | 811 | 125 | 5.72 | 53.56 | 47.22 | |
15 | Nature Reviews Clinical Oncology | journal | 12.214 Q1 | 217 | 145 | 586 | 7574 | 8429 | 274 | 14.14 | 52.23 | 35.91 | |
16 | Molecular Therapy - Oncolytics | journal | 1.424 Q1 | 42 | 153 | 149 | 7492 | 854 | 149 | 6.22 | 48.97 | 41.96 | |
17 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 16 | 21 | 741 | 98 | 19 | 5.00 | 46.31 | 50.63 | ||
18 | Future Oncology | journal | 0.857 Q3 | 90 | 294 | 1048 | 13111 | 2676 | 965 | 2.69 | 44.60 | 40.49 | |
19 | Cancer Cell International | journal | 1.322 Q2 | 80 | 565 | 665 | 25161 | 3384 | 665 | 5.19 | 44.53 | 40.45 | |
20 | Breast Cancer Research | journal | 2.378 Q1 | 175 | 129 | 428 | 5685 | 2593 | 423 | 5.63 | 44.07 | 52.60 | |
21 | Infectious Agents and Cancer | journal | 0.774 Q3 | 47 | 70 | 146 | 3035 | 417 | 146 | 2.70 | 43.36 | 39.52 | |
22 | Pigment Cell and Melanoma Research | journal | 1.618 Q1 | 120 | 70 | 222 | 2991 | 693 | 160 | 3.40 | 42.73 | 45.76 | |
23 | British Journal of Cancer | journal | 2.833 Q1 | 272 | 443 | 1155 | 18731 | 7285 | 1050 | 5.90 | 42.28 | 41.40 | |
24 | Neuro-Oncology Advances | journal | 26 | 169 | 28 | 7074 | 48 | 26 | 1.71 | 41.86 | 39.72 | ||
25 | Journal of Ovarian Research | journal | 1.154 Q2 | 61 | 138 | 300 | 5739 | 1256 | 299 | 4.05 | 41.59 | 49.43 | |
26 | Cancer Reports | journal | 0.261 Q4 | 18 | 66 | 82 | 2701 | 63 | 78 | 0.77 | 40.92 | 45.73 | |
27 | Immunotherapy | journal | 1.127 Q2 | 65 | 133 | 414 | 5441 | 1360 | 387 | 3.20 | 40.91 | 42.63 | |
28 | European Journal of Cancer Care | journal | 0.849 Q3 | 78 | 150 | 699 | 5976 | 1640 | 655 | 2.12 | 39.84 | 62.88 | |
29 | Melanoma Management | journal | 14 | 18 | 30 | 701 | 80 | 28 | 2.67 | 38.94 | 46.91 | ||
30 | Cancer Medicine | journal | 1.403 Q2 | 84 | 863 | 1598 | 33084 | 6927 | 1594 | 4.09 | 38.34 | 40.25 | |
31 | ecancermedicalscience | journal | 0.708 Q3 | 47 | 175 | 301 | 6657 | 735 | 298 | 2.18 | 38.04 | 40.99 | |
32 | Cancer Communications | journal | 2.119 Q1 | 79 | 74 | 210 | 2813 | 1408 | 171 | 7.43 | 38.01 | 44.10 | |
33 | Journal for ImmunoTherapy of Cancer | journal | 5.060 Q1 | 117 | 508 | 582 | 19284 | 7039 | 571 | 11.60 | 37.96 | 41.40 | |
34 | BMC Cancer | journal | 1.358 Q2 | 160 | 1203 | 3415 | 45082 | 14270 | 3411 | 4.14 | 37.47 | 40.48 | |
35 | Journal of Chemotherapy | journal | 0.515 Q3 | 56 | 67 | 185 | 2463 | 325 | 179 | 1.62 | 36.76 | 45.09 | |
36 | Cancer Treatment and Research Communications | journal | 0.459 Q3 | 23 | 98 | 92 | 3570 | 136 | 89 | 1.59 | 36.43 | 42.23 | |
37 | Hematological Oncology | journal | 0.918 Q2 | 54 | 107 | 393 | 3891 | 1002 | 324 | 2.72 | 36.36 | 41.94 | |
38 | Radiation Oncology | journal | 1.093 Q2 | 91 | 265 | 700 | 9483 | 2485 | 695 | 3.32 | 35.78 | 38.20 | |
39 | Lung Cancer Management | journal | 5 | 6 | 0 | 207 | 0 | 0 | 0.00 | 34.50 | 36.36 | ||
40 | Cancer Imaging | journal | 1.017 Q2 | 64 | 87 | 170 | 2988 | 612 | 170 | 3.73 | 34.34 | 35.86 | |
41 | Leukemia | journal | 4.539 Q1 | 219 | 386 | 1035 | 12827 | 8108 | 792 | 8.24 | 33.23 | 41.90 | |
42 | Psycho-Oncology | journal | 1.410 Q1 | 158 | 271 | 1009 | 9003 | 3206 | 947 | 2.81 | 33.22 | 64.99 | |
43 | Journal of Geriatric Oncology | journal | 1.032 Q2 | 53 | 234 | 348 | 7609 | 997 | 310 | 2.74 | 32.52 | 50.73 | |
44 | World Journal of Surgical Oncology | journal | 0.757 Q3 | 76 | 326 | 697 | 10531 | 1880 | 691 | 2.59 | 32.30 | 28.62 | |
45 | Clinical Oncology | journal | 1.037 Q2 | 89 | 173 | 454 | 5587 | 1144 | 303 | 2.55 | 32.29 | 41.53 | |
46 | Journal of Cancer Policy | journal | 0.563 Q3 | 20 | 50 | 123 | 1599 | 142 | 113 | 1.01 | 31.98 | 51.71 | |
47 | ESMO Open | journal | 2.409 Q1 | 60 | 225 | 300 | 7177 | 1446 | 234 | 4.65 | 31.90 | 42.35 | |
48 | Acta Oncologica | journal | 1.174 Q2 | 119 | 234 | 816 | 7460 | 2540 | 646 | 2.79 | 31.88 | 44.43 | |
49 | Prostate Cancer and Prostatic Diseases | journal | 2.000 Q1 | 78 | 89 | 217 | 2821 | 990 | 204 | 4.42 | 31.70 | 29.21 | |
50 | European Journal of Surgical Oncology | journal | 1.395 Q2 | 117 | 381 | 978 | 12072 | 3716 | 871 | 3.57 | 31.69 | 33.10 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®